GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)

Conditions: Testicular Neoplasms Interventions: Drug: Pegfilgrastim; Drug: Dactinomycin; Drug: Methotrexate; Drug: Etoposide; Drug: Cisplatin; Drug: Epirubicin Sponsors: Queen Mary University of London Completed

https://clinicaltrials.gov/study/NCT06309732

Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

More News: Methotrexate | Research